Cargando…

Vaccination against COVID-19: a challenge in CLL

Detalles Bibliográficos
Autor principal:	Eichhorst, Barbara
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	American Society of Hematology 2021
Materias:	BLOOD COMMENTARY
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8192082/ https://www.ncbi.nlm.nih.gov/pubmed/34110406 http://dx.doi.org/10.1182/blood.2021011935

Ejemplares similares

CLL and COVID-19: light at the end of the tunnel?
por: Scarfò, Lydia, et al.
Publicado: (2022)

Boosting BNT162b2 vaccine efficacy in CLL
por: Bhat, Seema A., et al.
Publicado: (2022)

COVID-19 in patients with CLL: improved survival outcomes and update on management strategies
por: Roeker, Lindsey E., et al.
Publicado: (2021)

Danger ahead: COVID-19 infections after vaccination
por: Greenberger, Lee M., et al.
Publicado: (2022)

Chronic lymphocytic leukemia management in Italy during the COVID-19 pandemic: a Campus CLL report
por: Cuneo, Antonio, et al.
Publicado: (2020)

Buckling up against COVID-19 after CAR T-cell therapy
por: Auletta, Jeffery J.
Publicado: (2022)

Hybrid immunity in immunocompromised patients with CLL after SARS-CoV-2 infection followed by booster mRNA vaccination
por: Blixt, Lisa, et al.
Publicado: (2022)

Curing CLL: one clone at a time
por: Aslan, Burcu, et al.
Publicado: (2022)

Another front in COVID-19’s perfect storm
por: Jobe, Shawn M., et al.
Publicado: (2021)

Thrombosis with COVID-19: kids get it too
por: Takemoto, Cliff
Publicado: (2021)

Vaccinations and ITP: keep on track(ing)
por: Bakchoul, Tamam, et al.
Publicado: (2022)

VITT(al) insights into vaccine-related clots
por: Strich, Jeffrey R., et al.
Publicado: (2021)

CLL-461 Humoral Response to COVID-19 Vaccine: A Challenge in CLL
por: Capasso, Antonella, et al.
Publicado: (2022)

Poster: CLL-461 Humoral Response to COVID-19 Vaccine: A Challenge in CLL
por: Capasso, Antonella, et al.
Publicado: (2022)

Immune thrombocytopenic purpura after vaccination with COVID-19 vaccine (ChAdOx1 nCov-19)
por: Paulsen, Finn-Ole, et al.
Publicado: (2021)

COVID-19 vaccines induce severe hemolysis in paroxysmal nocturnal hemoglobinuria
por: Gerber, Gloria F., et al.
Publicado: (2021)

Immune-mediated thrombotic thrombocytopenic purpura following COVID-19 vaccination
por: Picod, Adrien, et al.
Publicado: (2022)

A tale of two alleles: TP53 and transformation in MPNs
por: Brierley, Charlotte, et al.
Publicado: (2022)

COVID-19 in vaccinated adult patients with hematological malignancies: preliminary results from EPICOVIDEHA
por: Pagano, Livio, et al.
Publicado: (2022)

Cooling down VITT with IVIG
por: Lentz, Steven R.
Publicado: (2021)

Understanding VITT(ual) reality
por: Rauova, Lubica, et al.
Publicado: (2021)

Neutrophils clear sterile inflammatory debris
por: Yost, Christian Con
Publicado: (2021)

The race to stymie BTK: zanu zings
por: Kapoor, Prashant, et al.
Publicado: (2020)

Why B(-)other? About the gap of unknowns in ALL
por: Fioretos, Thoas
Publicado: (2022)

Tet2 helps blood cells balance in air
por: Chute, John P.
Publicado: (2022)

CD7 CAR: sword and shield
por: Velasquez, M. Paulina, et al.
Publicado: (2022)

Platelets get particular
por: Rauova, Lubica, et al.
Publicado: (2022)

The BTK inhibitor ibrutinib may protect against pulmonary injury in COVID-19–infected patients
por: Treon, Steven P., et al.
Publicado: (2020)

Impaired humoral responses to COVID-19 vaccination in patients with lymphoma receiving B-cell–directed therapies
por: Ghione, Paola, et al.
Publicado: (2021)

Humoral and cellular responses after COVID-19 vaccination in anti-CD20-treated lymphoma patients
por: Liebers, Nora, et al.
Publicado: (2022)

De novo and relapsed immune thrombocytopenia after COVID-19 vaccines: results of French safety monitoring
por: Moulis, Guillaume, et al.
Publicado: (2022)

The fight against the COVID-19 pandemic: Vaccination challenges in Sudan
por: Musa, Mohamed Babiker, et al.
Publicado: (2021)

Anti-CD38 therapy impairs SARS-CoV-2 vaccine response against alpha and delta variants in patients with multiple myeloma
por: Henriquez, Soledad, et al.
Publicado: (2022)

Use of convalescent plasma in hospitalized patients with COVID-19: case series
por: Hegerova, Livia, et al.
Publicado: (2020)

Hypersegmented granulocytes and COVID-19 infection
por: Salib, Christian, et al.
Publicado: (2020)

Anticoagulation in hospitalized patients with COVID-19
por: Baumann Kreuziger, Lisa, et al.
Publicado: (2022)

Low neutralizing antibody responses against SARS-CoV-2 in older patients with myeloma after the first BNT162b2 vaccine dose
por: Terpos, Evangelos, et al.
Publicado: (2021)

Vaccine-induced T-cell responses against SARS-CoV-2 and its Omicron variant in patients with B cell–depleted lymphoma after CART therapy
por: Atanackovic, Djordje, et al.
Publicado: (2022)

Vaccinations in CLL: implications for COVID-19
por: Shadman, Mazyar, et al.
Publicado: (2021)

COVID-19–induced atypical pulmonary lymphocytes
por: Vergé, Véronique, et al.
Publicado: (2020)

Cannot write session to /tmp/vufind_sessions/sess_04f6r2c0qqcji81rpi9hrjqjgs